Nuvectis Pharma (NVCT) Competitors $6.16 -0.35 (-5.38%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$6.36 +0.20 (+3.23%) As of 09/12/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVCT vs. TYRA, GOSS, PROK, DNA, BCAX, SNDL, SEPN, SVRA, MRVI, and ORGOShould you be buying Nuvectis Pharma stock or one of its competitors? The main competitors of Nuvectis Pharma include Tyra Biosciences (TYRA), Gossamer Bio (GOSS), ProKidney (PROK), Ginkgo Bioworks (DNA), Bicara Therapeutics (BCAX), SNDL (SNDL), Septerna (SEPN), Savara (SVRA), Maravai LifeSciences (MRVI), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry. Nuvectis Pharma vs. Its Competitors Tyra Biosciences Gossamer Bio ProKidney Ginkgo Bioworks Bicara Therapeutics SNDL Septerna Savara Maravai LifeSciences Organogenesis Nuvectis Pharma (NASDAQ:NVCT) and Tyra Biosciences (NASDAQ:TYRA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has preferable valuation & earnings, NVCT or TYRA? Tyra Biosciences is trading at a lower price-to-earnings ratio than Nuvectis Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNuvectis PharmaN/AN/A-$19M-$1.17-5.26Tyra BiosciencesN/AN/A-$86.48M-$1.78-7.03 Which has more volatility and risk, NVCT or TYRA? Nuvectis Pharma has a beta of -0.27, indicating that its stock price is 127% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Do institutionals and insiders hold more shares of NVCT or TYRA? 96.8% of Nuvectis Pharma shares are held by institutional investors. Comparatively, 84.1% of Tyra Biosciences shares are held by institutional investors. 30.5% of Nuvectis Pharma shares are held by company insiders. Comparatively, 15.2% of Tyra Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is NVCT or TYRA more profitable? Tyra Biosciences' return on equity of -31.22% beat Nuvectis Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Nuvectis PharmaN/A -150.81% -94.84% Tyra Biosciences N/A -31.22%-29.49% Do analysts recommend NVCT or TYRA? Nuvectis Pharma presently has a consensus target price of $15.33, suggesting a potential upside of 148.92%. Tyra Biosciences has a consensus target price of $31.86, suggesting a potential upside of 154.45%. Given Tyra Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Tyra Biosciences is more favorable than Nuvectis Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nuvectis Pharma 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Does the media favor NVCT or TYRA? In the previous week, Tyra Biosciences had 5 more articles in the media than Nuvectis Pharma. MarketBeat recorded 6 mentions for Tyra Biosciences and 1 mentions for Nuvectis Pharma. Nuvectis Pharma's average media sentiment score of 1.91 beat Tyra Biosciences' score of 0.98 indicating that Nuvectis Pharma is being referred to more favorably in the media. Company Overall Sentiment Nuvectis Pharma Very Positive Tyra Biosciences Positive SummaryTyra Biosciences beats Nuvectis Pharma on 8 of the 14 factors compared between the two stocks. Get Nuvectis Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVCT vs. The Competition Export to ExcelMetricNuvectis PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$165.72M$3.19B$5.84B$10.14BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-5.2621.4375.4125.98Price / SalesN/A432.54515.86180.60Price / CashN/A46.6837.5660.44Price / Book12.329.6112.156.29Net Income-$19M-$53.29M$3.29B$271.07M7 Day Performance-7.78%0.13%0.74%3.87%1 Month Performance-4.20%5.55%5.00%5.49%1 Year Performance-7.65%10.44%62.55%25.86% Nuvectis Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVCTNuvectis Pharma3.4754 of 5 stars$6.16-5.4%$15.33+148.9%-7.6%$165.72MN/A-5.268TYRATyra Biosciences2.4092 of 5 stars$12.13-4.1%$31.43+159.1%-41.1%$674.21MN/A-6.8120News CoverageAnalyst ForecastGOSSGossamer Bio3.976 of 5 stars$2.66-9.5%$8.50+219.5%+275.5%$668.50M$114.70M-4.29180Trending NewsAnalyst ForecastOptions VolumePROKProKidney3.6482 of 5 stars$2.16-4.0%$6.25+189.4%+3.8%$662.14M$80K-3.793News CoveragePositive NewsDNAGinkgo Bioworks1.8055 of 5 stars$11.19+0.3%$9.50-15.1%+58.5%$660.08M$227.04M-1.91640Positive NewsBCAXBicara Therapeutics2.1754 of 5 stars$12.29+1.9%$32.25+162.4%N/A$658.03MN/A-3.8832Positive NewsSNDLSNDL3.5572 of 5 stars$2.39-3.6%$4.50+88.3%+16.4%$651.68M$671.81M-8.852,516SEPNSepterna1.7732 of 5 stars$14.67+1.7%$26.75+82.3%N/A$643.36M$1.08M-1.45N/ANews CoverageAnalyst DowngradeSVRASavara3.2001 of 5 stars$3.85+3.5%$7.00+81.8%-15.2%$642.95MN/A-7.7020News CoverageAnalyst ForecastMRVIMaravai LifeSciences3.5342 of 5 stars$2.44-2.8%$5.22+113.9%-68.2%$640.96M$259.18M-1.79610Positive NewsGap UpORGOOrganogenesis3.9941 of 5 stars$4.77-4.6%$7.50+57.2%+75.4%$634.29M$482.04M-34.07950Positive NewsHigh Trading Volume Related Companies and Tools Related Companies TYRA Alternatives GOSS Alternatives PROK Alternatives DNA Alternatives BCAX Alternatives SNDL Alternatives SEPN Alternatives SVRA Alternatives MRVI Alternatives ORGO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVCT) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCT Stock Alerts